SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Inadvertent lung cancer screening results are discussed in a new study.

2.

EMA Backs Breast Cancer SERD After FDA No Vote

3.

Patellar Resurfacing in Total Knee Replacement; Patient Messaging Trends

4.

examining differences in the rates of breast reconstruction following mastectomies.

5.

Headlines About Doc Who 'Catches' Patient's Cancer Are Popping Up Again


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot